Skip to main content
. 2014 Dec 5;9(5):615–622. doi: 10.5009/gnl14032

Table 2.

Site of the Primary Tumors in the Study Patients (N=37)

Primary tumor No. (%)
Malignant melanoma 10 (27.0)
Lung 7 (18.9)
Breast 5 (13.5)
Gastrointestinal tract
 Esophagus 3 (8.1)
 Colorectum 2 (5.4)
Genitourinary tract
 Ovary 3 (8.1)
 Kidney 3 (8.1)
 Bladder 1 (2.7)
Choriocarcinoma 1 (2.7)
Head/neck 1 (2.7)
Neuroblastoma 1 (2.7)

ECOG, Eastern Cooperative Oncology Group.